Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (SHE:002399)

SHE:002399 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	May 12, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Market Capitalization	14,759	14,152	15,345	17,090	22,787	23,671
Market Cap Growth	34.44%	-7.78%	-10.21%	-25.00%	-3.74%	-2.72%
Enterprise Value	15,303	15,456	19,083	19,992	24,281	25,891
Last Close Price	11.08	10.69	11.73	12.74	16.91	16.87
PE Ratio	25.08	21.88	-	23.49	94.63	23.11
Forward PE	22.16	22.53	22.53	22.53	22.53	22.53
PS Ratio	2.80	2.69	2.83	2.39	3.58	4.44
PB Ratio	1.20	1.16	1.28	1.38	1.98	2.03
P/TBV Ratio	1.55	1.49	1.66	1.81	2.62	2.71
P/FCF Ratio	-	7.10	-	-	-	-
P/OCF Ratio	-	6.45	38.53	-	-	634.89
EV/Sales Ratio	2.90	2.94	3.51	2.79	3.82	4.86
EV/EBITDA Ratio	-	15.05	180.70	15.71	22.01	20.11
EV/EBIT Ratio	33.18	20.72	-	20.02	29.13	25.54
EV/FCF Ratio	-	7.75	-	-	-	-
Debt / Equity Ratio	0.29	0.29	0.46	0.52	0.49	0.48
Debt / EBITDA Ratio	-	3.33	38.64	4.95	4.98	4.28
Debt / FCF Ratio	-	1.78	-	-	-	-
Asset Turnover	0.29	0.29	0.27	0.36	0.33	0.31
Inventory Turnover	0.64	0.58	0.67	0.84	1.11	1.19
Quick Ratio	1.18	1.09	0.76	0.94	1.19	1.52
Current Ratio	2.55	2.60	2.13	2.22	2.25	2.53
Return on Equity (ROE)	5.12%	5.17%	-6.58%	5.97%	2.01%	10.66%
Return on Assets (ROA)	2.07%	2.55%	-0.68%	3.13%	2.73%	3.70%
Return on Capital (ROIC)	2.28%	2.80%	-0.75%	3.46%	3.02%	4.07%
Return on Capital Employed (ROCE)	4.40%	5.50%	-	6.60%	5.80%	6.60%
Earnings Yield	4.39%	4.57%	-5.10%	4.26%	1.06%	4.33%
FCF Yield	-	14.09%	-0.26%	-5.73%	-0.88%	-0.74%
Dividend Yield	2.27%	2.34%	-	0.78%	0.21%	0.89%
Payout Ratio	-	-	-	34.51%	171.31%	43.69%
Buyback Yield / Dilution	-0.05%	0.54%	-0.67%	-0.05%	-8.42%	-8.51%
Total Shareholder Return	2.22%	2.88%	-0.67%	0.73%	-8.21%	-7.62%

Updated Oct 30, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.